Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Sirpa Leppa; Judit Joergensen; Anne Tierens; Ingunn Ostlie; Unn Merete Fagerli; Peter de Nully Brown; Thomas S. Larsen; Susanna Mannisto; Lars Munksgaard; Martin Maisenholder; Kaija Vasala; Peter Meyer; Mats Jerkeman; Magnus Bjorkholm; Oystein Fluge; Sirkku Jyrkkio; Elisabeth Ralfkiaer; Signe Spetalen; Marja-Liisa Karjalainen-Lindsberg; Harald Holte

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Sirpa Leppa, Judit Joergensen, Anne Tierens, Ingunn Ostlie, Unn Merete Fagerli, Peter de Nully Brown, Thomas S. Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenholder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Bjorkholm, Oystein Fluge, Sirkku Jyrkkio, Elisabeth Ralfkiaer, Signe Spetalen, Marja-Liisa Karjalainen-Lindsberg, Harald Holte

Tutkimustuotos: Artikkelijulkaisu › Konferenssiesitelmän abstrakti › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Blood
Vuosikerta	128
Numero	22
Sivumäärä	6
ISSN	0006-4971
Tila	Julkaistu - 2 joulukuuta 2016
Tapahtuma	58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Kanada Kesto: 3 joulukuuta 2016 → 6 joulukuuta 2016

Siteeraa tätä

Leppa, S., Joergensen, J., Tierens, A., Ostlie, I., Fagerli, U. M., Brown, P. D. N., Larsen, T. S., Mannisto, S., Munksgaard, L., Maisenholder, M., Vasala, K., Meyer, P., Jerkeman, M., Bjorkholm, M., Fluge, O., Jyrkkio, S., Ralfkiaer, E., Spetalen, S., Karjalainen-Lindsberg, M-L., & Holte, H. (2016). Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial). Blood, 128(22).

Leppa, Sirpa ; Joergensen, Judit ; Tierens, Anne ; Ostlie, Ingunn ; Fagerli, Unn Merete ; Brown, Peter de Nully ; Larsen, Thomas S. ; Mannisto, Susanna ; Munksgaard, Lars ; Maisenholder, Martin ; Vasala, Kaija ; Meyer, Peter ; Jerkeman, Mats ; Bjorkholm, Magnus ; Fluge, Oystein ; Jyrkkio, Sirkku ; Ralfkiaer, Elisabeth ; Spetalen, Signe ; Karjalainen-Lindsberg, Marja-Liisa ; Holte, Harald. / Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial). Julkaisussa: Blood. 2016 ; Vuosikerta 128, Nro 22.

@article{591269b174874f83999aab812ab34d10,

title = "Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)",

author = "Sirpa Leppa and Judit Joergensen and Anne Tierens and Ingunn Ostlie and Fagerli, {Unn Merete} and Brown, {Peter de Nully} and Larsen, {Thomas S.} and Susanna Mannisto and Lars Munksgaard and Martin Maisenholder and Kaija Vasala and Peter Meyer and Mats Jerkeman and Magnus Bjorkholm and Oystein Fluge and Sirkku Jyrkkio and Elisabeth Ralfkiaer and Signe Spetalen and Marja-Liisa Karjalainen-Lindsberg and Harald Holte",

year = "2016",

month = dec,

day = "2",

language = "English",

volume = "128",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "22",

note = "58th Annual Meeting and Exposition of the American-Society-of-Hematology ; Conference date: 03-12-2016 Through 06-12-2016",

}

Leppa, S, Joergensen, J, Tierens, A, Ostlie, I, Fagerli, UM, Brown, PDN, Larsen, TS, Mannisto, S, Munksgaard, L, Maisenholder, M, Vasala, K, Meyer, P, Jerkeman, M, Bjorkholm, M, Fluge, O, Jyrkkio, S, Ralfkiaer, E, Spetalen, S, Karjalainen-Lindsberg, M-L & Holte, H 2016, 'Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)', Blood, Vuosikerta 128, Nro 22.

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial). / Leppa, Sirpa; Joergensen, Judit; Tierens, Anne; Ostlie, Ingunn; Fagerli, Unn Merete; Brown, Peter de Nully; Larsen, Thomas S.; Mannisto, Susanna; Munksgaard, Lars; Maisenholder, Martin; Vasala, Kaija; Meyer, Peter; Jerkeman, Mats; Bjorkholm, Magnus; Fluge, Oystein; Jyrkkio, Sirkku; Ralfkiaer, Elisabeth; Spetalen, Signe; Karjalainen-Lindsberg, Marja-Liisa; Holte, Harald.

julkaisussa: Blood, Vuosikerta 128, Nro 22, 02.12.2016.

Tutkimustuotos: Artikkelijulkaisu › Konferenssiesitelmän abstrakti › vertaisarvioitu

TY - JOUR

T1 - Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

AU - Leppa, Sirpa

AU - Joergensen, Judit

AU - Tierens, Anne

AU - Ostlie, Ingunn

AU - Fagerli, Unn Merete

AU - Brown, Peter de Nully

AU - Larsen, Thomas S.

AU - Mannisto, Susanna

AU - Munksgaard, Lars

AU - Maisenholder, Martin

AU - Vasala, Kaija

AU - Meyer, Peter

AU - Jerkeman, Mats

AU - Bjorkholm, Magnus

AU - Fluge, Oystein

AU - Jyrkkio, Sirkku

AU - Ralfkiaer, Elisabeth

AU - Spetalen, Signe

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Holte, Harald

PY - 2016/12/2

Y1 - 2016/12/2

M3 - Meeting Abstract

VL - 128

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

T2 - 58th Annual Meeting and Exposition of the American-Society-of-Hematology

Y2 - 3 December 2016 through 6 December 2016

ER -